Methylpiperidinopyrazole (MPP) is a synthetic, nonsteroidal, and highly selective antagonist of ERñ that is used in scientific research to study the function of this receptor. It has 200-fold selectivity for ERñ over ERò and 1000-fold selectivity for blocking ERñ-mediated gene transcription relative to that of ERò.